About Index Trending news
Lists
Pricing
Cellectis

Cellectis

Cellectis

Cellectis is a biopharmaceutical company. The company’s mission is to develop a novel generation of therapy based on allogeneic T-cells to treat cancer.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series C)
$6,913,608
Venture capital (Series B)
$7,223,476
Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cellectis makes some noise.